BIOQUAL, Inc.
BIOQ
$38.50
-$0.01-0.03%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.98M | 9.86M | 11.67M | 14.03M | 11.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.98M | 9.86M | 11.67M | 14.03M | 11.40M |
| Cost of Revenue | 9.97M | 8.98M | 5.59M | 11.30M | 11.51M |
| Gross Profit | 1.01M | 875.60K | 6.08M | 2.73M | -113.60K |
| SG&A Expenses | 1.42M | 1.39M | 6.20M | 1.56M | 1.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.39M | 10.37M | 11.79M | 12.86M | 13.22M |
| Operating Income | -410.30K | -518.80K | -118.20K | 1.17M | -1.82M |
| Income Before Tax | -189.50K | -343.40K | 26.30K | 1.29M | -1.67M |
| Income Tax Expenses | -52.20K | -94.60K | 123.00K | 355.30K | -460.20K |
| Earnings from Continuing Operations | -137.30K | -248.80K | -96.70K | 936.00K | -1.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -137.30K | -248.80K | -96.70K | 936.00K | -1.21M |
| EBIT | -410.30K | -518.80K | -118.20K | 1.17M | -1.82M |
| EBITDA | 156.70K | 47.50K | 447.60K | 1.77M | -1.23M |
| EPS Basic | -0.15 | -0.28 | -0.11 | 1.05 | -1.36 |
| Normalized Basic EPS | -0.13 | -0.24 | 0.02 | 0.90 | -1.17 |
| EPS Diluted | -0.15 | -0.28 | -0.11 | 1.05 | -1.36 |
| Normalized Diluted EPS | -0.13 | -0.24 | 0.02 | 0.90 | -1.17 |
| Average Basic Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Average Diluted Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Dividend Per Share | -- | -- | 0.50 | -- | -- |
| Payout Ratio | -- | -- | 0.00% | 0.00% | -36.89% |